Biocon News

Active Pine is expected to divest up to 1% equity in Biocon, valued at Rs 638 crore, through a block deal, coinciding with Biocon's 10-year partnership in Brazi

Biocon has secured a ten-year contract in Brazil for the distribution of its breast cancer drug Pertuzumab, partnering with Bahiafarma and Bionovis to supply th

SMC Global has recommended Happiest Minds, Biocon, and Apollo Micro as top stock picks for short-term gains, noting that Happiest Minds is showing signs of a bu

In July 2026, mutual funds increased their stock exposure across large-, mid-, and small-cap segments, with significant buying in sectors like banking, financia

Biocon shares increased by 2% following the USFDA's supplemental approval for its subsidiary's Yesintek single-dose prefilled autoinjectors. This approval expan

Biocon's Kiran Mazumdar-Shaw believes US generics tariffs are more of a negotiation tactic than a real threat, with the company exploring potential manufacturin

Biocon reported a 9% year-on-year rise in Q1 total income to 4,391 crore rupees for FY27, with biopharma revenue increasing by 17%. The company's EBITDA stood a

Biocon has reported a significant increase in its Q1 net profit, which surged fourfold to reach Rs 141 crore.

Several prominent companies, including Power Grid Corporation of India, Cummins India, PB Fintech, Whirlpool of India, and Biocon, are scheduled to announce the

Biocon has received approval from Health Canada for its Yesintek autoinjector pen, offering a convenient treatment option for patients with psoriasis, psoriatic

Kiran Mazumdar-Shaw revealed that the loss of her best friend to cancer motivated her to establish Biocon. She realized that Biocon's success in making insulin

Mylan sold a ₹1,839 crore stake in Biocon through a block deal, with ICICI Prudential Mutual Fund emerging as the largest buyer alongside other institutional in

Despite a Sensex decline, four BSE 150 Midcap stocks, including Biocon, The Phoenix Mills, Ipca Laboratories, and Laurus Labs, reached new 52-week highs, indica

Several major stocks, including HCL Technologies, Biocon, SBI, Grasim, BEL, ICICI Prudential AMC, Timken India, Poonawalla Fincorp, and Alembic Pharma, are expe

Mylan is expected to sell Biocon shares worth Rs 3,481 crore today in a block deal, with the floor price set at Rs 378.50 per share, a 7.9% discount to Biocon's

Mylan is launching a block deal to sell a minority stake in Biocon for up to $363 million, aiming to offload 92 million equity shares as part of a financial exi

Mylan Inc. reportedly plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd., a stake valued at up to $363 million, according to a term sheet see

On July 10, five NSE F&O stocks, including Paytm, CDSL, and Biocon, saw a sharp rise of over 6% in futures open interest, indicating increased trader activity a